NO970783L - Fremgangsmåte for å hindre endometrialkreft - Google Patents
Fremgangsmåte for å hindre endometrialkreftInfo
- Publication number
- NO970783L NO970783L NO970783A NO970783A NO970783L NO 970783 L NO970783 L NO 970783L NO 970783 A NO970783 A NO 970783A NO 970783 A NO970783 A NO 970783A NO 970783 L NO970783 L NO 970783L
- Authority
- NO
- Norway
- Prior art keywords
- endometrial cancer
- procedure
- preventing
- preventing endometrial
- hexamethylenimino
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
- A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
- A61K31/4535—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a heterocyclic ring having sulfur as a ring hetero atom, e.g. pizotifen
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/4025—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil not condensed and containing further heterocyclic rings, e.g. cromakalim
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/53—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with three nitrogens as the only ring hetero atoms, e.g. chlorazanil, melamine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
Landscapes
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Urology & Nephrology (AREA)
- Endocrinology (AREA)
- Reproductive Health (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Pyrrole Compounds (AREA)
- Hydrogenated Pyridines (AREA)
Abstract
Fremgangsmåte for å hindre endometrialkreft ^-^^...JX&i^i¿^ (D i -(Ci-C,.al)cyl) (a) 0 II -c-xr (b) Det er beskrevet en fremgangsmåte for inhibering av endometrialkreft som iimbefatter at det til et menneske som har behov for dette administreres en effektiv mengde av en forbindelse av formel (I), hvor R^ og r3 uavhengig av hverandre er hydrogen, -CH3, (a) eller (b), hvor Ar er evenUielt substituert fenyl; r2 er valgt fra gruppen bestående av pyrrolidin, heksametylenimino eller piperidino; eller et farmaseytisk akseptabelt salt eller solvat derav.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US29385394A | 1994-08-22 | 1994-08-22 | |
PCT/US1995/010651 WO1996005833A1 (en) | 1994-08-22 | 1995-08-21 | Methods of inhibiting endometrial cancer |
Publications (2)
Publication Number | Publication Date |
---|---|
NO970783L true NO970783L (no) | 1997-02-20 |
NO970783D0 NO970783D0 (no) | 1997-02-20 |
Family
ID=23130867
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO970783A NO970783D0 (no) | 1994-08-22 | 1997-02-20 | Fremgangsmåte for å hindre endometrialkreft |
Country Status (17)
Country | Link |
---|---|
EP (1) | EP0777476A4 (no) |
JP (1) | JPH10504824A (no) |
KR (1) | KR970705387A (no) |
AU (1) | AU688112B2 (no) |
CA (1) | CA2198119A1 (no) |
CZ (1) | CZ51897A3 (no) |
FI (1) | FI970717A (no) |
HU (1) | HUT76890A (no) |
IL (1) | IL115022A (no) |
MX (1) | MX9701327A (no) |
MY (1) | MY113757A (no) |
NO (1) | NO970783D0 (no) |
NZ (1) | NZ292017A (no) |
RU (1) | RU2161964C2 (no) |
TW (1) | TW404834B (no) |
WO (1) | WO1996005833A1 (no) |
ZA (1) | ZA956994B (no) |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5856340A (en) * | 1995-02-28 | 1999-01-05 | Eli Lilly And Company | Method of treating estrogen dependent cancers |
US6465445B1 (en) | 1998-06-11 | 2002-10-15 | Endorecherche, Inc. | Medical uses of a selective estrogen receptor modulator in combination with sex steroid precursors |
US7005428B1 (en) | 1998-06-11 | 2006-02-28 | Endorecherche, Inc. | Medical uses of a selective estrogen receptor modulator in combination with sex steroid precursors |
KR20160066490A (ko) * | 2014-12-02 | 2016-06-10 | 주식회사 씨앤드씨신약연구소 | 헤테로사이클 유도체 및 그의 용도 |
CN115825414B (zh) * | 2023-01-09 | 2023-04-25 | 中国医学科学院北京协和医院 | 血液或尿液代谢标志物及其在子宫内膜癌早筛中的应用 |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4418068A (en) * | 1981-04-03 | 1983-11-29 | Eli Lilly And Company | Antiestrogenic and antiandrugenic benzothiophenes |
JP3157882B2 (ja) * | 1991-11-15 | 2001-04-16 | 帝国臓器製薬株式会社 | 新規なベンゾチオフエン誘導体 |
US5482949A (en) * | 1993-03-19 | 1996-01-09 | Eli Lilly And Company | Sulfonate derivatives of 3-aroylbenzo[b]thiophenes |
CA2160135A1 (en) * | 1993-04-07 | 1994-10-13 | Donald P. Mcdonnell | Method for screening for receptor agonists |
ES2179063T3 (es) * | 1993-10-15 | 2003-01-16 | Lilly Co Eli | Procedimientos para tratar neoplasmas resistentes. |
DK0771201T3 (da) * | 1994-08-22 | 2001-05-07 | Lilly Co Eli | Anvendelse af 2-phenyl-3-aroylbenzothiophener til fremstilling af et medikament til inhibering af primær endometrisk hyperplasi |
US5843964A (en) * | 1994-09-22 | 1998-12-01 | Eli Lilly And Company | Methods of inhibiting endometrial mitoses |
-
1995
- 1995-08-21 CZ CZ97518A patent/CZ51897A3/cs unknown
- 1995-08-21 JP JP8508265A patent/JPH10504824A/ja active Pending
- 1995-08-21 EP EP95930243A patent/EP0777476A4/en not_active Withdrawn
- 1995-08-21 IL IL11502295A patent/IL115022A/xx not_active IP Right Cessation
- 1995-08-21 KR KR1019970701095A patent/KR970705387A/ko not_active Application Discontinuation
- 1995-08-21 MX MX9701327A patent/MX9701327A/es unknown
- 1995-08-21 WO PCT/US1995/010651 patent/WO1996005833A1/en not_active Application Discontinuation
- 1995-08-21 MY MYPI95002449A patent/MY113757A/en unknown
- 1995-08-21 RU RU97104160/14A patent/RU2161964C2/ru active
- 1995-08-21 CA CA002198119A patent/CA2198119A1/en not_active Abandoned
- 1995-08-21 HU HU9701499A patent/HUT76890A/hu unknown
- 1995-08-21 NZ NZ292017A patent/NZ292017A/en unknown
- 1995-08-21 ZA ZA9506994A patent/ZA956994B/xx unknown
- 1995-08-21 TW TW084108700A patent/TW404834B/zh not_active IP Right Cessation
- 1995-08-21 AU AU33700/95A patent/AU688112B2/en not_active Ceased
-
1997
- 1997-02-20 FI FI970717A patent/FI970717A/fi unknown
- 1997-02-20 NO NO970783A patent/NO970783D0/no not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
AU3370095A (en) | 1996-03-14 |
TW404834B (en) | 2000-09-11 |
JPH10504824A (ja) | 1998-05-12 |
MY113757A (en) | 2002-05-31 |
HUT76890A (en) | 1997-12-29 |
FI970717A0 (fi) | 1997-02-20 |
ZA956994B (en) | 1997-02-21 |
IL115022A0 (en) | 1998-06-15 |
EP0777476A4 (en) | 1999-06-23 |
CA2198119A1 (en) | 1996-02-29 |
MX9701327A (es) | 1997-05-31 |
RU2161964C2 (ru) | 2001-01-20 |
NZ292017A (en) | 2000-07-28 |
AU688112B2 (en) | 1998-03-05 |
IL115022A (en) | 2000-07-31 |
WO1996005833A1 (en) | 1996-02-29 |
NO970783D0 (no) | 1997-02-20 |
FI970717A (fi) | 1997-02-20 |
EP0777476A1 (en) | 1997-06-11 |
CZ51897A3 (en) | 1997-06-11 |
KR970705387A (ko) | 1997-10-09 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NO971520L (no) | Fremgangsmåte for hemming av tilstander forbundet med neuropeptid Y | |
NO944928L (no) | Fremgangsmåter for inhibering av Alzheimers sykdom | |
NO973635L (no) | Fremgangsmåte for hemming av celle-celle adhesjon | |
MX9701360A (es) | Metodos para la inhibicion de la desmielinizacion y las enfermedades de la dismielinizacion. | |
GR3027706T3 (en) | Inhibition of dysfunctional uterine bleeding. | |
NO944925L (no) | Fremgangsmåte for å öke libido i post-menopausale kvinner | |
NO944933L (no) | Fremgangsmåte for å inhibere sykdomstilstander i brystet | |
NO970786L (no) | Fremgangsmåte for hemming av benprotesedegradering | |
NO944924L (no) | Fremgangsmåter for inhibering av Turner's syndrom | |
NO975580L (no) | Fremgangsmåte for å inhibere melanom | |
NO944917D0 (no) | Anvendelse av 2-fenyl-3-aroyltiofener for inhibering av eggstokkdysgenese, forsinket pubertet eller seksuell infantilisme | |
NO970783L (no) | Fremgangsmåte for å hindre endometrialkreft | |
NO973367L (no) | Fremgangsmåte for å inhibere miljömessige östrogen | |
NO981578L (no) | FremgangsmÕte for hemming av plasminogenaktivatorhemmer I | |
NO973609L (no) | Fremgangsmåte for å inhibere effektene av IL-6 | |
NO971794L (no) | Fremgangsmåte for hemming av tilstander forbundet med bradykinin | |
NO971029L (no) | Fremgangsmåter for hemming av endometriale metoser | |
NO973103L (no) | Fremgangsmåte for inhibering av veksthormoneffekter | |
IL115016A (en) | Benzothiophene derivatives for bone healing and fracture repair pharmaceutical compositions comprising same and uses thereof | |
NO970787D0 (no) | Fremgangsmåte for hemming av primær endometrial hyperplasi | |
NO983452L (no) | FremgangsmÕter for Õ hemme muskuloaponeurotisk fibromatose (desmoide tumorer) | |
NO944909L (no) | Fremgangsmåter for inhibering av mannlig infertilitet | |
NO983451L (no) | FremgangsmÕte for hemming av colontumorer | |
NO973470L (no) | Fremgangsmåte for minsking av serumkalsiumnivåer |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FC2A | Withdrawal, rejection or dismissal of laid open patent application |